Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products

This study addresses the balance struck under the Trans-Pacific Partnership Agreement (TPPA) between the right to health and access to medicines and the need to maintain the economic incentives to spur innovation and research and development through intellectual property protection. The analysis foc...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Artecona, Raquel, Plank-Brumback, Rosine M.
Formato:	Texto
Lenguaje:	English
Publicado:	ECLAC 2016
Materias:	ACUERDOS ECONOMICOS COMERCIO INTERNACIONAL NEGOCIACIONES COMERCIALES PRODUCTOS FARMACEUTICOS INNOVACIONES PATENTES PROPIEDAD INTELECTUAL ECONOMIC AGREEMENTS INTERNATIONAL TRADE TRADE NEGOTIATIONS PHARMACEUTICALS INNOVATIONS PATENTS INTELLECTUAL PROPERTY
Acceso en línea:	http://hdl.handle.net/11362/40729
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai-11362-40729
record_format	dspace
spelling	oai-11362-407292020-11-25T22:58:09Z Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products Artecona, Raquel Plank-Brumback, Rosine M. ACUERDOS ECONOMICOS COMERCIO INTERNACIONAL NEGOCIACIONES COMERCIALES PRODUCTOS FARMACEUTICOS INNOVACIONES PATENTES PROPIEDAD INTELECTUAL ECONOMIC AGREEMENTS INTERNATIONAL TRADE TRADE NEGOTIATIONS PHARMACEUTICALS INNOVATIONS PATENTS INTELLECTUAL PROPERTY This study addresses the balance struck under the Trans-Pacific Partnership Agreement (TPPA) between the right to health and access to medicines and the need to maintain the economic incentives to spur innovation and research and development through intellectual property protection. The analysis focuses on the patent and data-related intellectual property protection provisions of the TPPA, specifically regarding pharmaceutical (small-molecule and biologic) products, including on patent duration, linkage and term extensions as well as clinical test data protection and market exclusivity. Special attention is paid to the United States and its negotiating position with respect to those aspects of intellectual property rights, as it has been and remains the world’s principal demandeur for high intellectual property rights (IPR) standards in trade agreements, including the TPPA. Abstract .-- Introduction .-- I. Key trends in the global, regional and U.S. pharmaceutical industries .-- II. Patent and regulatory data-related protection on pharmaceutical products in TPP .-- III. Congressional mandates on intellectual property protection on pharmaceutical products .-- IV. Conclusions. 2016-11-11T15:30:56Z 2016-11-11T15:30:56Z 2016-11 Texto Documento Completo http://hdl.handle.net/11362/40729 LC/L.4248 LC/WAS/L.143 en Studies and Perspectives Series (Washington, DC) 16 .pdf application/pdf ESTADOS UNIDOS UNITED STATES ECLAC
institution	Cepal
collection	Cepal
language	English
topic	ACUERDOS ECONOMICOS COMERCIO INTERNACIONAL NEGOCIACIONES COMERCIALES PRODUCTOS FARMACEUTICOS INNOVACIONES PATENTES PROPIEDAD INTELECTUAL ECONOMIC AGREEMENTS INTERNATIONAL TRADE TRADE NEGOTIATIONS PHARMACEUTICALS INNOVATIONS PATENTS INTELLECTUAL PROPERTY
spellingShingle	ACUERDOS ECONOMICOS COMERCIO INTERNACIONAL NEGOCIACIONES COMERCIALES PRODUCTOS FARMACEUTICOS INNOVACIONES PATENTES PROPIEDAD INTELECTUAL ECONOMIC AGREEMENTS INTERNATIONAL TRADE TRADE NEGOTIATIONS PHARMACEUTICALS INNOVATIONS PATENTS INTELLECTUAL PROPERTY Artecona, Raquel Plank-Brumback, Rosine M. Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products
description	This study addresses the balance struck under the Trans-Pacific Partnership Agreement (TPPA) between the right to health and access to medicines and the need to maintain the economic incentives to spur innovation and research and development through intellectual property protection. The analysis focuses on the patent and data-related intellectual property protection provisions of the TPPA, specifically regarding pharmaceutical (small-molecule and biologic) products, including on patent duration, linkage and term extensions as well as clinical test data protection and market exclusivity. Special attention is paid to the United States and its negotiating position with respect to those aspects of intellectual property rights, as it has been and remains the world’s principal demandeur for high intellectual property rights (IPR) standards in trade agreements, including the TPPA.
format	Texto
author	Artecona, Raquel Plank-Brumback, Rosine M.
author_facet	Artecona, Raquel Plank-Brumback, Rosine M.
author_sort	Artecona, Raquel
title	Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products
title_short	Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products
title_full	Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products
title_fullStr	Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products
title_full_unstemmed	Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products
title_sort	access to medicines and incentives for innovation: the balance struck in the trans-pacific partnership (tpp) on intellectual property (patent and data exclusivity) protection for pharmaceutical products
publisher	ECLAC
publishDate	2016
url	http://hdl.handle.net/11362/40729
work_keys_str_mv	AT arteconaraquel accesstomedicinesandincentivesforinnovationthebalancestruckinthetranspacificpartnershiptpponintellectualpropertypatentanddataexclusivityprotectionforpharmaceuticalproducts AT plankbrumbackrosinem accesstomedicinesandincentivesforinnovationthebalancestruckinthetranspacificpartnershiptpponintellectualpropertypatentanddataexclusivityprotectionforpharmaceuticalproducts
_version_	1718442388308885504

Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products

Ejemplares similares